Status:
COMPLETED
Hybrid Model of Vocal Inflammation and Tissue Mobilization
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
McGill University
Conditions:
Acute Phonotrauma
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to generate a technology that will allow clinicians to prescribe behavioral treatment that should optimize tissue healing for both acute and chronic phonotrauma. In this s...
Eligibility Criteria
Inclusion
- healthy females
- ages 18-40
- generally healthy
- normal hearing bilaterally at 20 dB to 8,000 Hz
- have ability to produce "resonant voice" during training as determined by the examiner perceptually
- Tolerate rigid and nasal endoscopy without anesthesia to the larynx nasal patency allowing for the passage of an endoscope unilaterally
Exclusion
- Smoking within the past five yr
- Failing a hearing screening test
- Having current chronic voice problems
- Having current medications that are determined to possibly influence voice
- Having heightened gag reflex
- Having known or suspected allergy to anesthetics
- Pregnancy reported
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01197339
Start Date
September 1 2010
End Date
March 1 2013
Last Update
January 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univesity of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260